363 related articles for article (PubMed ID: 7841033)
21. Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers.
Yu MY; Tong JH; Chan PK; Lee TL; Chan MW; Chan AW; Lo KW; To KF
Int J Cancer; 2003 Jun; 105(2):204-9. PubMed ID: 12673680
[TBL] [Abstract][Full Text] [Related]
22. Identification of p53 and human papilloma virus in Schneiderian papillomas.
Mirza N; Montone K; Sato Y; Kroger H; Kennedy DW
Laryngoscope; 1998 Apr; 108(4 Pt 1):497-501. PubMed ID: 9546259
[TBL] [Abstract][Full Text] [Related]
23. Highly differentiated keratinizing squamous cell cancer of the cervix.
Rubinstein E
Am J Surg Pathol; 2002 May; 26(5):676; author reply 676. PubMed ID: 11979099
[No Abstract] [Full Text] [Related]
24. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
[TBL] [Abstract][Full Text] [Related]
25. High level HPV-16 E7 oncoprotein expression correlates with reduced pRb-levels in cervical biopsies.
Fiedler M; Müller-Holzner E; Viertler HP; Widschwendter A; Laich A; Pfister G; Spoden GA; Jansen-Dürr P; Zwerschke W
FASEB J; 2004 Jul; 18(10):1120-2. PubMed ID: 15155561
[TBL] [Abstract][Full Text] [Related]
26. The prognostic significance of HPV-16 genome status of the lymph nodes, the integration status and p53 genotype in HPV-16 positive cervical cancer: a long term follow up.
Hernádi Z; Szarka K; Sápy T; Krasznai Z; Veress G; Póka R
BJOG; 2003 Feb; 110(2):205-9. PubMed ID: 12618167
[TBL] [Abstract][Full Text] [Related]
27. [Human papillomavirus, human cytomegalovirus and p53 gene in cervical carcinoma].
Zhao W; Si J; Li K
Zhonghua Fu Chan Ke Za Zhi; 1995 Nov; 30(11):654-7. PubMed ID: 8745488
[TBL] [Abstract][Full Text] [Related]
28. A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques.
Ziegert C; Wentzensen N; Vinokurova S; Kisseljov F; Einenkel J; Hoeckel M; von Knebel Doeberitz M
Oncogene; 2003 Jun; 22(25):3977-84. PubMed ID: 12813471
[TBL] [Abstract][Full Text] [Related]
29. Presence of p53 mutation in human cervical carcinomas associated with HPV-33 infection.
Lo KW; Mok CH; Chung G; Huang DP; Wong F; Chan M; Lee JC; Tsao SW
Anticancer Res; 1992; 12(6B):1989-94. PubMed ID: 1363512
[TBL] [Abstract][Full Text] [Related]
30. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
[TBL] [Abstract][Full Text] [Related]
31. p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy.
Ganly I; Soutar DS; Brown R; Kaye SB
Br J Cancer; 2000 Jan; 82(2):392-8. PubMed ID: 10646894
[TBL] [Abstract][Full Text] [Related]
32. Mutations in the p53 gene and human papillomavirus infection as significant prognostic factors in squamous cell carcinomas of the oral cavity.
Chiba I; Shindoh M; Yasuda M; Yamazaki Y; Amemiya A; Sato Y; Fujinaga K; Notani K; Fukuda H
Oncogene; 1996 Apr; 12(8):1663-8. PubMed ID: 8622886
[TBL] [Abstract][Full Text] [Related]
33. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix.
Ferguson AW; Svoboda-Newman SM; Frank TS
Mod Pathol; 1998 Jan; 11(1):11-8. PubMed ID: 9556417
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical detection of p53 in cervical epithelial lesions with or without infection of human papillomavirus types 16 and 18.
Akasofu M; Oda Y
Virchows Arch; 1995; 425(6):593-602. PubMed ID: 7697216
[TBL] [Abstract][Full Text] [Related]
35. The effects of p53 status and human papillomavirus infection on the clinical outcome of patients with stage IIIB cervical carcinoma treated with radiation therapy alone.
Ishikawa H; Mitsuhashi N; Sakurai H; Maebayashi K; Niibe H
Cancer; 2001 Jan; 91(1):80-9. PubMed ID: 11148563
[TBL] [Abstract][Full Text] [Related]
36. The presence of HPV 16, 18 and p53 immunohistochemical staining in tumor tissue of Israeli Jewish women with cervical and vulvar neoplasia.
Menczer J; Fintsi Y; Arbel-Alon S; Tell L; Friedman E; Jackman A; Sherman L
Eur J Gynaecol Oncol; 2000; 21(1):30-4. PubMed ID: 10726615
[TBL] [Abstract][Full Text] [Related]
37. p53 mutations in cervical carcinogenesis--low frequency and lack of correlation with human papillomavirus status.
Busby-Earle RM; Steel CM; Williams AR; Cohen B; Bird CC
Br J Cancer; 1994 Apr; 69(4):732-7. PubMed ID: 8142262
[TBL] [Abstract][Full Text] [Related]
38. Squamous cell carcinoma of the endometrium with human papillomavirus type 31 and without tumor suppressor gene p53 mutation.
Kataoka A; Nishida T; Sugiyama T; Hori K; Honda S; Yakushiji M
Gynecol Oncol; 1997 Apr; 65(1):180-4. PubMed ID: 9103411
[TBL] [Abstract][Full Text] [Related]
39. Pathogenetic significance of p53 and c-Ki-ras gene mutations and human papillomavirus DNA integration in adenocarcinoma of the uterine cervix and uterine isthmus.
Jiko K; Tsuda H; Sato S; Hirohashi S
Int J Cancer; 1994 Dec; 59(5):601-6. PubMed ID: 7960232
[TBL] [Abstract][Full Text] [Related]
40. Correlation between HPV positivity and state of the p53 gene in cervical carcinoma cell lines.
Iwasaka T; Oh-uchida M; Matsuo N; Yokoyama M; Fukuda K; Hara K; Fukuyama K; Hori K; Sugimori H
Gynecol Oncol; 1993 Jan; 48(1):104-9. PubMed ID: 8380785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]